​

Quoin Pharmaceuticals Stock (NASDAQ:QNRX)

RevenueOwnershipFinancialsChartTranscripts
Quoin Pharmaceuticals by TradingView

Previous Close

$0.33

52W Range

$0.30 - $6.18

50D Avg

$0.62

200D Avg

$0.64

Market Cap

$1.67M

Avg Vol (3M)

$2.50M

Beta

1.89

Div Yield

-

QNRX Company Profile

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

Yes

Country

US

Employees

4

IPO Date

Aug 01, 2016

Website

QNRX Performance

QNRX Financial Summary

Dec 23Dec 22Dec 21
Revenue---
Operating Income$-9.35M$-8.85M$-20.37M
Net Income$-8.66M$-9.28M$-8.52M
EBITDA$-8.69B$-8.74M$-20.27M
Basic EPS$-9.62$-45.96$-323.63
Diluted EPS$-9.62$-45.96$-323.63

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q4 23Mar 14, 24 | 8:30 AM
Q3 23Nov 09, 23 | 8:30 AM
Q2 23Aug 07, 23 | 8:30 AM

Peer Comparison

TickerCompany
BDRXBiodexa Pharmaceuticals Plc
ALLRAllarity Therapeutics, Inc.
VRAXVirax Biolabs Group Limited
REVBRevelation Biosciences, Inc.
CDIOCardio Diagnostics Holdings, Inc.
UNCYUnicycive Therapeutics, Inc.